Log in

Effectiveness and tolerability of long-acting intramuscular risperidone as adjuvant treatment in refractory borderline personality disorder

  • Letter to the Editor
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

References

Download references

Acknowledgments

This research was partially supported by a grant for research from the Ministry of Science and Innovation FIS 09–0331.

Conflict of interest

None of the authors have any financial interests or conflicts possibly affecting the objectives or the results of the present manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. L. Carrasco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carrasco, J.L., Palomares, N. & Marsá, M.D. Effectiveness and tolerability of long-acting intramuscular risperidone as adjuvant treatment in refractory borderline personality disorder. Psychopharmacology 224, 347–348 (2012). https://doi.org/10.1007/s00213-012-2880-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-012-2880-0

Keywords

Navigation